ReviewNaunyn-Schmiedeberg's archives of pharmacology2025

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease.

Dipanjan Karati et al.PubMed ↗Publisher ↗

No numbers read from the abstract.